Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance
Open Access
- 31 May 2006
- journal article
- Published by Elsevier BV in Trends in Molecular Medicine
- Vol. 12 (5), 200-205
- https://doi.org/10.1016/j.molmed.2006.03.005
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6The Lancet, 2005
- Amplification ofPlasmodium falciparumMultidrug Resistance Gene 1 in Isolates from GabonThe Journal of Infectious Diseases, 2005
- Enantiomeric 1,2,4‐Trioxanes Display Equivalent in vitro Antimalarial Activity Versus Plasmodium falciparum Malaria Parasites: Implications for the Molecular Mechanism of Action of the ArtemisininsChemBioChem, 2005
- Yeast Model Uncovers Dual Roles of Mitochondria in the Action of ArtemisininPLoS Genetics, 2005
- Three-dimensional structure of Plasmodium falciparum Ca2+-ATPase(PfATP6) and docking of artemisinin derivatives to PfATP6Bioorganic & Medicinal Chemistry Letters, 2005
- Artemisinins: mechanisms of action and potential for resistanceDrug Resistance Updates, 2004
- Identification of an antimalarial synthetic trioxolane drug development candidateNature, 2004
- Artemisinins target the SERCA of Plasmodium falciparumNature, 2003
- Neurotoxic Mode of Action of ArtemisininAntimicrobial Agents and Chemotherapy, 2002
- A family of cation ATPase-like molecules from Plasmodium falciparum.The Journal of cell biology, 1993